JP Stock MarketDetailed Quotes

4563 AnGes

Watchlist
  • 70
  • -1-1.41%
20min DelayMarket Closed Apr 25 15:30 JST
23.35BMarket Cap-0.59P/E (Static)

About AnGes Company

AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.

Company Profile

Symbol4563
Company NameAnGes
Founded1999-12-17
MarketTSE Growth
Employees55
Fiscal Year Ends12-31
Address7-7-15, Saito-asagi 4F, Saito Bio-Incubator
Zip Code108-0014
Phone---

Company Executives

  • Name
  • Position
  • Salary
  • Ei Yamada
  • Representative Director , President and Chief Executive Officer
  • --
  • Shoya Satou
  • Director
  • --
  • Norikazu Eiki
  • Independent Director
  • --
  • Makoto Hara
  • Independent Director
  • --
  • Kimiko Murofushi
  • Independent Director
  • --
  • Junichi Komamura
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More